RILEXINE DC 375 MG INTRAMAMMARY SUSPENSION FOR DRY COWS
RILEXINE DC 375 MG INTRAMAMMARY SUSPENSION FOR DRY COWS
Authorised
- Cephalexin benzathine
Product identification
Medicine name:
RILEXINE DC 375 MG INTRAMAMMARY SUSPENSION FOR DRY COWS
Rilexine DC 375 mg Suspensie voor intramammair gebruik
Rilexine DC 375 mg Suspension intramammaire
Rilexine DC 375 mg Suspension zur intramammären Anwendung
Active substance:
- Cephalexin benzathine
Target species:
-
Cattle (cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cephalexin benzathine500.00milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
- Cattle (cow)
-
Meat and offal4dayMeat and offal: 4 days
-
Milk43day42.5 days after treatment when dry period is 42 days or less
-
Milk12hour12 hours after calving when dry period is more than 42 days
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51DB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Box of 24 x 8g intramammary syringes and 24 cleaning towels
- Box of 60 x 8g intramammary syringes and 60 cleaning towels
- Box of 12 x 8g intramammary syringes and 12 cleaning towels
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Latina S.r.l.
- Virbac
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V599182
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0438/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
Germany
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?: